期刊文献+

吴茱萸次碱的合成、结构表征及体内抗肿瘤作用研究 被引量:5

Synthesis,Structure Characterization of Rutaecarpine and Its Antitumor Activity in vivo
下载PDF
导出
摘要 以色胺和靛红酸酐为起始原料经三步反应合成吴茱萸次碱,通过元素分析I、R、质谱1、HNMR等对合成的目标化合物进行了表征,并考察了吴茱萸次碱对小鼠移植性肉瘤S180和肝癌H22的影响。结果表明,吴茱萸次碱高、中、低剂量组(20 mg.kg-11、0 mg.kg-1和5 mg.kg-1)对S180和H22的生长均具有抑制作用;且和环磷酰胺相比,对脾脏和胸腺损伤更小,甚至具有保护作用。 Rutaecarpine was obtained successfully with tryptamine and isatoic anhydride as raw material through three-step reaction.And the aim compound was characterized by elemental analysis,IR,MS,and 1HNMR.And the antitumor activity in vivo of rutaecarpine for S180 and H22 in mice were studied.The results showed that rutaecarpine of high,medium and low dose(20 mg·kg-1,10 mg·kg-1 and 5 mg·kg-1) could inhibit the growth of both S180 and H22 significantly.And comparing with the cyclophosphamide,the rutaecarpine did little damage to spleen and thymus,even had protection effect.
出处 《化学与生物工程》 CAS 2010年第10期37-40,共4页 Chemistry & Bioengineering
基金 陕西省教育厅专项科研计划项目(09JK393) 中药制药重点学科资助课题
关键词 吴茱萸次碱 合成 结构表征 体内抗肿瘤活性 rutaecarpine synthesis structure characterization antitumor activity in vivo
  • 相关文献

参考文献14

二级参考文献121

共引文献250

同被引文献35

  • 1刘保林,吴巍巍,靳长峰,王音.吴茱萸次碱对小鼠溃疡性肠炎的治疗作用[J].中国临床药理学与治疗学,2004,9(11):1273-1277. 被引量:27
  • 2刘勇,崔颖鹏,宋涛,杨栋梁.吴茱萸次碱促进脑组织降钙素基因相关肽释放减轻脑缺血-再灌注损伤[J].中国医师杂志,2005,7(5):589-591. 被引量:9
  • 3余奇,郭澄,程泽能.吴茱萸次碱的研究进展[J].药学实践杂志,2007,25(6):353-357. 被引量:22
  • 4Jia S J,Hu C P.Pharmacological effects of rutaecarpine as a cardiovascular protective agent.Molecules,2010;15(3)∶1873~1881.
  • 5Yu P L,Chao H L,Wang S W,et al.Effects of evodiamine and rutaecarpine on the secretion of corticosterone by zona fasciculata-reticularis cells in male rats.Journal of Cellular.Biochemistry,2009;108(2)∶469~475.
  • 6Kim S J,Lee S J,Lee S,et al.Rutaecarpine ameliorates bodyweight gain through the inhibition of orexigenic neuropeptides NPY and AgRP in mice.Biochemical and Biophysical.Research Communications,2009;389(3)∶437~442.
  • 7Liao J F,Chiou W F,Shen Y C,et al.Anti-inflammatory and anti-infectious effects of Evodia rutaecarpa(Wuzhuyu)and its major bioactive components.Chinese Medicine,2011;6(1)∶6~14.
  • 8Martins G R.,Napolitano H B,Camargo L T F M,et al.Structure-activity relationship study of rutaecarpine analogous cctive against central nervous system cancer.Journal of the Brazilian Chemical Society,2012;123(12)∶2183~2190.
  • 9Kim S I,Lee S H,Lee E S,et al.New Topoisomerases Inhibitors∶Synthesis of rutaecarpine derivatives and their inhibitory activity against topoisomerases.Archives of Pharmacal Research,2012;35(5)∶785~789.
  • 10LI Y J,Zhang F,Gong Q H,et al.Rutaecarpine inhibits angiotensinⅡ-induced proliferation in rat vascular smooth muscle cells.Chinese Journal of Integrative Medicine,2013;1~6.

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部